ES2062100T3 - Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento. - Google Patents

Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento.

Info

Publication number
ES2062100T3
ES2062100T3 ES89830491T ES89830491T ES2062100T3 ES 2062100 T3 ES2062100 T3 ES 2062100T3 ES 89830491 T ES89830491 T ES 89830491T ES 89830491 T ES89830491 T ES 89830491T ES 2062100 T3 ES2062100 T3 ES 2062100T3
Authority
ES
Spain
Prior art keywords
treatment
carnitine
acetyl
cataracts
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89830491T
Other languages
English (en)
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2062100T3 publication Critical patent/ES2062100T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ES DESCRITO EL USO DE CARNITINA-L ACETIL Y SUS SALES ACEPTABLES FARMACOLOGICAMENMTE EN EL TRATAMIENTO TERAPEUTICO DE CATARATAS. EL MEDICAMENTO DEBE SER ADMINISTRADO ORALMENTE U ORIGINALMENTE O ES APLICADO COMO UN COLIRIO QUE CONTIENE APROXIMADAMENTE DEL 10-15% W/V DE CARNITINA-L ACETIL.
ES89830491T 1988-11-15 1989-11-13 Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento. Expired - Lifetime ES2062100T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848558A IT1235153B (it) 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento

Publications (1)

Publication Number Publication Date
ES2062100T3 true ES2062100T3 (es) 1994-12-16

Family

ID=11267312

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89830491T Expired - Lifetime ES2062100T3 (es) 1988-11-15 1989-11-13 Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento.

Country Status (8)

Country Link
US (1) US5037851A (es)
EP (1) EP0375628B1 (es)
JP (1) JPH02180820A (es)
AT (1) ATE99172T1 (es)
DE (1) DE68911891T2 (es)
ES (1) ES2062100T3 (es)
IT (1) IT1235153B (es)
ZA (1) ZA898667B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
AU764807B2 (en) * 1998-07-30 2003-08-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
ES2272351T3 (es) * 2000-12-15 2007-05-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de l-carnitina como agente estabilizante de proteinas.
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
WO2007003481A1 (en) * 2005-07-01 2007-01-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
MX2007016048A (es) 2005-07-08 2008-03-10 Sigma Tau Ind Farmaceuti Uso de una combinacion que comprende l-carnitina o alcanoil l-carnitina, benzoquinona soluble en lipido y acidos grasos poliinsaturados omega 3 para la preparacion de un suplemento dietetico o medicamento para el tratamiento de enfermedades de la cor
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
US9114120B2 (en) 2010-11-22 2015-08-25 Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. Therapeutical method for the treatment of the Leber optic neuropathy
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock

Also Published As

Publication number Publication date
DE68911891D1 (de) 1994-02-10
ATE99172T1 (de) 1994-01-15
EP0375628A3 (en) 1991-08-14
EP0375628A2 (en) 1990-06-27
IT1235153B (it) 1992-06-22
DE68911891T2 (de) 1994-04-21
EP0375628B1 (en) 1993-12-29
JPH02180820A (ja) 1990-07-13
ZA898667B (en) 1990-10-31
IT8848558A0 (it) 1988-11-15
US5037851A (en) 1991-08-06

Similar Documents

Publication Publication Date Title
ES2062100T3 (es) Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento.
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
AR015940A1 (es) Derivados de rapamicina que contiene tetrazol con vidas medias acortadas y su uso para la manufactura de un medicamento
FI940787A0 (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
MX9402339A (es) Formulacion de proteina.
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
NO306377B1 (no) Doseform for avgivelse av et medikament
ES2070478T3 (es) El empleo de acetil l-carnitina en el tratamiento terapeutico de coma.
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
YU49390A (sh) Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
IT1181682B (it) Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
ITMI932189A1 (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
ES2037654T3 (es) Conjugado de 9-(2-hidroxietoximetil)-guanina con albumina humana lactosaminada, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
ES2063079T3 (es) Una composicion farmaceutica que tiene efecto sinergico basada en sulbactam y metampicilina.
PH12021550037A1 (en) Pharmaceutical composition in the form of a chewable tablet of diosmin or of a flavonoid moiety
ITMI931598A1 (it) Uso terapeutico della fosfocreatina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 375628

Country of ref document: ES